Influenza structure
Protein layer
Lipid bilayer
hemagglutinin (HA)
neuraminidase (NA)
M2 Ion channel
Single stranded RNA
RNA in 8 pieces
Antigenic Drift
Repeated mutations cause gradual change in HA and NA
1/48
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Influenza structure
Protein layer
Lipid bilayer
hemagglutinin (HA)
neuraminidase (NA)
M2 Ion channel
Single stranded RNA
RNA in 8 pieces
Antigenic Drift
Repeated mutations cause gradual change in HA and NA
Antigenic Shift
Sudden shift is caused when the virus acquires genome segments from another influenza virus by recombination
Influenza Causative organism
Influenza A, B, and C viruses
enveloped, ssRNA in 8 segments
Influenza Mode of transmission
Droplet contact— coughs and sneezes
Direct contact— handshake
Indirect contact— fomite
Influenza Pathogenesis
Infection of respiratory epithelium causes lysis
Secondary infections results from damage to the mucociliary escalator
Influenza virulence factors
Hemagglutinin—for attachment, binds to sialic acid receptors
Neuraminidase— for release, removes sialic acid from cell surface
Influenza symptoms
Fever, headache, sore throat, cough, runny nose, muscle aches (myalgia)
Influenza Prevention
Killed injected vaccine or inhaled line attenuated vaccine taken annually
Hand washing
Influenza Distinctive features
Antigens can shift or drift
Polio causative organism
Poliovirus, ssRNA non-enveloped
Polio Mode of Transmission
Fecal-oral, vehicle
Polio Virulence factors
Attachment mechanisms
Polio symptoms
Initially, Sore throat and nausea
Viremia may occur; if persistent, the virus can enter the CNS
Destruction of motor cells and paralysis occur in <1% of cases
Polio Prevention
Live attenuated (OPV) Sabin vaccine
Inactivated vaccine (IPV) Salk vaccine preferred in US
Rabies Causative organism
Rabies lyssavirus
ssRNA enveloped
Rabies transmission
Parenteral (bite trauma), droplet contact
Rabies virulence factors
Envelope glycoprotein enables to spread to CNS
Rabies symptoms
Initial stages: include hydrophobia
Furious rabies: Animals are restless, the highly excitable
Paralytic rabies: Animals seem unaware of surroundings
Rabies Prevention
HDCV—Human Diploid Cell rabies Vaccine—an inactivated vaccine
Rabies treatment
Post-exposure antiserum and active immunization
Smallpox Causative organism
Variola virus, enveloped dsDNA virus
Smallpox Mode of transmission
Droplet contact, indirect contact
Smallpox Signs & symptoms
Fever, prostration, rash, toxemia, and shock
Smallpox Virulence factors
Ability to dampen and avoid immune response
Smallpox Prevention
Live virus vaccine—vaccinia virus
Smallpox Treatment
Immunoglobulin—passive immunity
Measles Causative organism
Measles morbillivirus formerly known as Measles virus ssRNA, enveloped
Measles Mode of transmission
Droplet contact via respiratory portal
Measles signs & symptoms
Maculopapular rash
Koplick spots in the mouth
Measles Virulence factors
Syncytium formation, ability to suppress cell-mediated immunity
Measles Prevention
Live attenuated vaccine (MMR)
Measles Complications
diarrhea (8%)
Otitis media (7%)
Pneumonia (6%)
Leading cause of death in adults— acute encephalitis (0.1%)
Carlos Findlay
A Cuban doctor proposes mosquito transmission rather than human contact
Walter Reed
Proved the mosquito transmission hypothesis
Let lab raised mosquitos feed on yellow fever patients
Then on members of the commission
Yellow Fever eliminated from Havana through mosquito control
Later use to control mosquitos in the Panama Canal Zone enabling its construction
Yellow fever causative organism
Yellow fever virus, ssRNA enveloped
Yellow fever Transmission
Bite of the Aedes aegypti mosquito
Yellow fever Signs & Symptoms
Most cases— mild infection - fever, headache, chills, back pain, fatigue, loss of appetite, muscle pain, nausea, and vomiting
15% of cases recurring fever, jaundice, bleeding from mouth and eyes, black vomit
Yellow fever Virulence factors
Disruption of blood clotting factors
Death may occurs form cytokine storm and shock
Yellow fever treatment
Supportive care
Yellow fever Prevention
Repellant, proper clothing, avoid being outside at peak biting times
Live attenuated vaccine
Malaria
bad air
Most common serious infectious disease worldwide
Over 200 million infected annually today
More than 450,000 deaths per year
In 1955, WHO program for global elimination
Initially successful—52 nations participated
Mosquito vectors developed resistance
1976, WHO acknowledged failure
Ronald Ross
In 1902 received the Nobel Prize for demonstrating life cycle of protozoan causing malaria
Malaria Causative organism
Plasmodium falciparum, P. vivax, P. ovale, P. malariae, P. knowlesi
Malaria Mode of transmission
Biological vector— bite of mosquito
Humans are the primary host
Malaria Symptoms and signs
Cyclic symptoms correlate with the parasite’s life cycle
Fever, chills, sweating every 48 to 72 hrs as red blood cells lyse—combination of symptoms called a paroxysm
Malaria Virulence factors
Multiple antigenic types to evade the immune response
Ability to scavenge glucose
Cyto-adherence
Invasion of RBCs
Malaria Prevention
Mosquito control
Use of bed nets
No vaccine available
Prophylactic anti-protozoal agent
Malaria Treatment
Artemisinin- based Combination Treatment (ACT)